CVRx, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CVRx, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $35.00K, a 9.38% increase year-over-year.
- CVRx, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $32.00K, a 92.33% decline year-over-year.
- CVRx, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $196.00K, a 81.99% decline year-over-year.
- CVRx, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $148.00K, a 79.67% decline year-over-year.
- CVRx, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $793.00K, a 70.61% decline from fiscal 2024.
- CVRx, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $2.70M, a 270.60% increase from fiscal 2023.
- CVRx, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $728.00K, a 295.65% increase from fiscal 2022.
- CVRx, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $184.00K, a 700.00% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $35.00K 10-Q · filed 2026-08-06 | $411.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $32.00K 10-Q · filed 2026-05-12 | $408.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $793.00K 10-K · filed 2026-02-13 |
| 2025-09-30 | $148.00K 10-Q · filed 2025-11-06 | $1.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $32.00K 10-Q · filed 2026-08-06 | $2.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $417.00K 10-Q · filed 2026-05-12 | $2.30M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.70M 10-K · filed 2026-02-13 |
| 2024-09-30 | $728.00K 10-Q · filed 2025-11-06 | $1.82M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $67.00K 10-Q · filed 2025-08-05 | $1.45M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $815.00K 10-Q · filed 2025-05-09 | $1.42M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $728.00K 10-K · filed 2025-02-18 |
| 2023-09-30 | $363.00K 10-Q · filed 2024-11-01 | $622.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $28.00K 10-Q · filed 2024-08-02 | $266.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $128.00K 10-Q · filed 2024-05-10 | $264.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $184.00K 10-K · filed 2024-02-09 |
| 2022-09-30 | $7.00K 10-Q · filed 2023-10-31 | $94.00K derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $26.00K 10-Q · filed 2023-08-03 | $95.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $48.00K 10-Q · filed 2023-05-11 | $69.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $23.00K 10-K · filed 2023-02-10 |
| 2021-09-30 | $8.00K 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |